Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.

Journal of Crohn's & colitis - 1 Jul 2017

De Vries L C S, Wildenberg M E, De Jonge W J, D'Haens G R

Abstract excerpt

Inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, are disabling conditions characterised by chronic, relapsing inflammation of the gastrointestinal tract. Current treatments are not universally effective or, in the case of therapeutic antibodies, are hampered by immune responses. Janus kinase inhibitors are orally delivered small molecules that target cytokine signalling by preventing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokines
Share to Inflammatory Bowel Diseases
Share to Janus Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperidines

Share to Pyrimidines

Share to Pyrroles

Share to Signal Transduction

Share to STAT Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 28158411
DOI: 10.1093/ecco-jcc/jjx003
PMCID: PMC5881740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.PMID 28158411Read ↗

JAK selectivity: more precision less troublesSemantic proximity Read ↗

JAK–STAT pathway targeting for the treatment of inflammatory bowel diseaseSemantic proximity Read ↗

Molecular Structure and Function of Janus Kinases: Implications for the Development of InhibitorsSemantic proximity Read ↗

Janus kinase inhibitors in autoimmune diseasesSemantic proximity Read ↗

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseasesSemantic proximity Read ↗

Immunomodulators in inflammatory bowel disease: an emerging role for biologic agents.Semantic proximity Read ↗

The many faces of Janus kinase.Semantic proximity Read ↗

Protein kinases are potential targets to treat inflammatory bowel diseaseSemantic proximity Read ↗

Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s diseaseSemantic proximity Read ↗

The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative ColitisSemantic proximity Read ↗

Upadacitinib: Mechanism of action, clinical, and translational scienceSemantic proximity Read ↗

Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.